A meta-analysis of 31 RCTs (n = 2676) evaluated the efficacy and safety of prostaglandin E1 (PGE1) in combination with ALA for treating DPN
Dihexa or its analogs were administered 5 minutes after scopolamine, either intracerebroventricularly at doses of 0.1 or 1 nmol), intraperitoneally at doses of 0.05, 0.25, or 0.50 mg/kg, or orally at doses of 1.25 or 2.0 mg/kg
Dermatology Dermatologists diagnose and treat skin conditions
Moreover, pretreatment on the petiole of the wounded leaf with LaCl 3 severely reduced the GSH-inducible expression of defense genes in systemic leaves (Fig
Tc dng h tr iu tr tim mch: - au tht ngc: Nhiu bng chng ch ra rng Carnitine c th c s dng kt hp vi cc thuc iu tr thng thng trong cc trng hp au tht ngc
A newer formulation (Egrifta WR) delivers 1.28mg daily with equivalent efficacy through improved bioavailability